Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
基本信息
- 批准号:6959665
- 负责人:
- 金额:$ 59.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:behavior modificationbehavior therapybehavioral /social science research tagclinical researchcommunity mental health servicescomorbiditycorrectional institutionscriminal behaviordata collection methodology /evaluationdrug abusehealth care modelhuman subjecthuman therapy evaluationlongitudinal human studymathematical modelmental healthoutcomes researchpatient care managementpsychosocial rehabilitationsocial behavior disorders
项目摘要
DESCRIPTION (provided by applicant):
Offenders having both mental illness and chemical abuse (MICA) disorders are a population of interest, in part because their special needs place exceptional demands on criminal justice and treatment systems, as well as on individuals and families. The proposed study examines the crucial point of transition from prison to the community, where continued treatment for offenders is generally considered necessary to sustain gains made by prison treatment efforts, and to achieve successful outcomes. On their release from prison, male offenders with MICA disorders who elect to participate in this study (N = 332), will be placed in either the experimental condition, (E) Re-entry Modified Therapeutic Community (Re-entry MTC) or the control condition, (C) Parole Supervision and Case Management currently provided, using a randomized block assignment procedure. The research employs a prospective, longitudinal, repeated measures assessment with five data collection points: baseline (Time 1, or T1) corresponding to entry into the Community Corrections facility and at 3 (T2), 6 (T3), 12 (T4), and 18 (T5) months post-baseline. The major study hypothesis is that the E condition (compared to the C condition) will produce significantly greater improvement in the presenting problems of the study participants, as measured by substance use, mental health symptoms, and criminal activities.
This project will advance scientific knowledge through a controlled study of the effectiveness of the MTC model, with demonstrated success in community settings, as a re-entry strategy for offenders with MICA disorders, thereby expanding the range of treatment models available to such clients in the community. In addition, the study will examine the degree to which prior prison treatment moderates the effectiveness of the Re-entry MTC, or the extent to which positive outcomes are independent of the type of treatment received during the prior incarceration. This distinction will inform program planning by establishing the value of MTC treatment in prison plus MTC during re-entry versus MTC re-entry treatment alone. Finally, the study tests a specific hypothesis about the degree to which the effectiveness of Re-entry MTC treatment is mediated by client progress during reentry, which will increase our understanding of the relationship between progress in treatment and post-treatment outcomes for offenders with MICA disorders.
描述(由申请人提供):
患有精神疾病和化学品滥用障碍的罪犯是一个令人关注的群体,部分原因是他们的特殊需要对刑事司法和治疗系统以及个人和家庭提出了特殊要求。拟议的研究审查了从监狱向社区过渡的关键点,在社区,一般认为继续治疗罪犯是维持监狱治疗工作取得的成果和取得成功的必要条件。在他们从监狱释放时,选择参加本研究的患有云母障碍的男性罪犯(N = 332)将被置于实验条件(E)再进入改良治疗社区(再进入MTC)或对照条件(C)假释监督和案件管理,目前提供,使用随机区组分配程序。该研究采用前瞻性,纵向,重复测量评估,有五个数据收集点:基线(时间1,或T1)对应于进入社区矫正设施和3(T2),6(T3),12(T4),和18(T5)个月后基线。主要的研究假设是,E条件(与C条件相比)将对研究参与者的现有问题产生显着更大的改善,如物质使用,心理健康症状和犯罪活动。
该项目将通过对MTC模式的有效性进行对照研究来推进科学知识,该模式在社区环境中取得了成功,作为患有云母疾病的罪犯的重返社会战略,从而扩大了社区中此类客户可用的治疗模式的范围。此外,该研究还将审查以前的监狱待遇在多大程度上缓和了重返MTC的有效性,或积极成果在多大程度上独立于以前监禁期间接受的待遇类型。这一区别将通过确定监狱中MTC治疗加上重返社会期间MTC与单独MTC重返社会治疗的价值,为方案规划提供信息。最后,该研究测试了一个具体的假设,即在多大程度上重返MTC治疗的有效性是由客户端在重返过程中的进展介导的,这将增加我们对云母疾病罪犯的治疗进展和治疗后结果之间的关系的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stanley Sacks其他文献
Stanley Sacks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stanley Sacks', 18)}}的其他基金
Region 2 ATTC: NJ, NY, PR & the U.S. VI
区域 2 ATTC:新泽西州、纽约州、波多黎各
- 批准号:
8549023 - 财政年份:2012
- 资助金额:
$ 59.04万 - 项目类别:
Region 2 ATTC: NJ, NY, PR & the U.S. VI
区域 2 ATTC:新泽西州、纽约州、波多黎各
- 批准号:
8541254 - 财政年份:2012
- 资助金额:
$ 59.04万 - 项目类别:
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders
对患有药物滥用障碍的罪犯进行计算机化心理社会治疗
- 批准号:
7855764 - 财政年份:2009
- 资助金额:
$ 59.04万 - 项目类别:
Computerized Psychosocial Treatment for Offenders with Substance Use Disorders
对患有药物滥用障碍的罪犯进行计算机化心理社会治疗
- 批准号:
7941747 - 财政年份:2009
- 资助金额:
$ 59.04万 - 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
- 批准号:
7474754 - 财政年份:2005
- 资助金额:
$ 59.04万 - 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
- 批准号:
7106372 - 财政年份:2005
- 资助金额:
$ 59.04万 - 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
- 批准号:
7667957 - 财政年份:2005
- 资助金额:
$ 59.04万 - 项目类别:
Re-Entry MTC for Offenders with MICA Disorders
患有 MICA 疾病的罪犯重新进入 MTC
- 批准号:
7257106 - 财政年份:2005
- 资助金额:
$ 59.04万 - 项目类别:
NDRI Rocky Mountain Research Center for CJDATS 2
NDRI 落基山研究中心 CJDATS 2
- 批准号:
7681427 - 财政年份:2002
- 资助金额:
$ 59.04万 - 项目类别:
NDRI Rocky Mountain Research Center for CJDATS 2
NDRI 落基山研究中心 CJDATS 2
- 批准号:
7789440 - 财政年份:2002
- 资助金额:
$ 59.04万 - 项目类别:
相似海外基金
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
- 批准号:
480808 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Miscellaneous Programs
Function of cost bias and effect of cognitive behavior therapy on social anxiety in children and adolescents
成本偏差的作用及认知行为治疗对儿童青少年社交焦虑的影响
- 批准号:
23K02970 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide: A Pilot RCT
辩证行为疗法和数字认知行为疗法相结合治疗自杀高危青少年的失眠:一项试点随机对照试验
- 批准号:
10643478 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
A Randomized Clinical Trial Comparing Transdiagnostic Behavior Therapy to Disorder-Specific Psychotherapy in the Recovery of Veterans with Social Anxiety Disorder and Comorbid PTSD Symptomatology
一项随机临床试验,比较跨诊断行为疗法与特定障碍心理疗法在患有社交焦虑症和共病 PTSD 症状的退伍军人康复中的作用
- 批准号:
10746930 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.
降低 AD/ADRD 患者老年护理人员的自杀风险:调整、实施和评估辩证行为治疗技能培训干预措施。
- 批准号:
10730708 - 财政年份:2023
- 资助金额:
$ 59.04万 - 项目类别:
A Randomized control trial of behavior therapy of tics in Japan. Exploring the behavior model of tics.
日本抽动行为治疗的随机对照试验。
- 批准号:
22K13840 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder
行为疗法联合丁丙诺啡治疗阿片类药物使用障碍的作用
- 批准号:
10440820 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10429841 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效
- 批准号:
10656415 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:
Efficacy of digital cognitive behavior therapy for insomnia for the prevention of perinatal depression - supplement
数字认知行为疗法治疗失眠预防围产期抑郁症的疗效 - 补充
- 批准号:
10794868 - 财政年份:2022
- 资助金额:
$ 59.04万 - 项目类别:














{{item.name}}会员




